A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Clinical trial NCT03958799 · COMPLETED

Trial details

NCT number: NCT03958799
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tetanus Immunisation (Healthy Volunteers)Diphtheria Immunisation (Healthy Volunteers)Pertussis Immunisation (Healthy Volunteers)

Start date: 2019-06-26
Primary completion: 2021-04-06
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.